1-36088936-G-A
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting
The NM_017825.3(ADPRS):c.32G>A(p.Gly11Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000275 in 1,524,650 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_017825.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADPRS | NM_017825.3 | c.32G>A | p.Gly11Asp | missense_variant | 1/6 | ENST00000373178.5 | NP_060295.1 | |
ADPRS | XM_011541636.3 | c.-334G>A | 5_prime_UTR_variant | 1/5 | XP_011539938.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADPRS | ENST00000373178.5 | c.32G>A | p.Gly11Asp | missense_variant | 1/6 | 1 | NM_017825.3 | ENSP00000362273 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152174Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000428 AC: 5AN: 116924Hom.: 0 AF XY: 0.0000308 AC XY: 2AN XY: 65030
GnomAD4 exome AF: 0.0000160 AC: 22AN: 1372476Hom.: 0 Cov.: 32 AF XY: 0.0000133 AC XY: 9AN XY: 677326
GnomAD4 genome AF: 0.000131 AC: 20AN: 152174Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74320
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 02, 2023 | The c.32G>A (p.G11D) alteration is located in exon 1 (coding exon 1) of the ADPRHL2 gene. This alteration results from a G to A substitution at nucleotide position 32, causing the glycine (G) at amino acid position 11 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at